Lung Cancer
Epidemiology and Overview of Lung Cancer
Lung cancer represents the leading cause of cancer-related mortality, accounting for approximately (nearly one-third) of all cancer deaths.
In the United States, approximately new cases of lung cancer are diagnosed annually, accompanied by a markedly high mortality rate.
Most inpatient oncology care takes place on dedicated oncology units, with admissions to the Intensive Care Unit (ICU) typically reserved for acute, life-threatening complications.
The clinical presentation of lung cancer varies; it may present as a discrete, isolated tumor or manifest based on the specific pulmonary cell types involved.
Surgical interventions depend on tumor location and staging, ranging from wedge/segmental resections to complete lobectomies (such as the removal of a malignant tumor in a right upper lobe observed at Del Webb hospital).
Etiology and Risk Factors
Tobacco smoking is the single most critical etiology, implicated in of all primary lung malignancies through direct active inhalation or secondary exposure (secondhand smoke).
Smoking represents the most readily modifiable risk factor for lung cancer, though behavioral modification is often hindered by physical addiction.
Occupational and environmental exposures constitute significant secondary causes:
Asbestos exposure directly correlates with the development of mesothelioma and bronchogenic carcinoma.
High-risk occupations include mining, firefighting, and industrial manufacturing.
Modern workplace interventions implemented by the Occupational Safety and Health Administration (OSHA)—including specialized particulate respirators and engineering controls—often arrive too late for workers who accumulated decades of prior unmitigated exposure.
Smoking cessation requires of complete abstinence for pulmonary parenchyma and airway function to approximate the baseline status of a non-smoker.
Cessation is foundational in managing concurrent pulmonary diseases, particularly Chronic Obstructive Pulmonary Disease (COPD), which is almost universally linked to primary or secondary smoke exposure.
Tumor Kinetics and Anatomic Distribution
The minimum tumor diameter detectable on a standard screening chest X-ray is .
The biological growth rate of bronchogenic carcinoma is prolonged, typically requiring for an occult malignant lesion to reach the detectable threshold of .
Patients routinely smoke tobacco products (e.g., Marlboro's) for years without overt symptoms while subclinical, undetectable neoplastic lesions expand internally.
Neoplastic lesions arise most frequently in the segmental bronchi and the upper pulmonary lobes, correlating directly with the primary physical flow paths and deposition zones of inhaled carcinogens.
Histological Classification and Systemic Therapies
Lung neoplasms are broadly divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), each possessing distinct therapeutic algorithms, treatment responses, and survival statistics (referenced in textbook Chart 23-13):
Small Cell Lung Cancer (SCLC): Represents approximately of all lung cancer cases. It is the most aggressive and hardest form to survive, carrying the lowest survival rates. Systemic chemotherapy serves as the absolute mainstay of treatment, as surgical resection is virtually never indicated.
Non-Small Cell Lung Cancer (NSCLC): Includes histological variants such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Surgical resection is generally not attempted in large cell carcinomas, whereas other localized forms may qualify for surgical excision.
Primary oncologic treatment modalities include:
Surgical resection (curative or debulking).
Radiation therapy (definitive or palliative).
Systemic chemotherapy.
Adjunctive immunotherapies designed to stimulate and enhance the host immune system to eradicate malignant cells.
Clinical application of immunotherapy (Mayo Clinic case study):
A patient presenting with Stage IV melanoma with no underlying comorbidities was managed with surgical excision combined with aggressive immunotherapy to augment endogenous immune surveillance, resulting in complete disease remission.
Immunotherapy is not universally indicated and requires individualized oncologist evaluation based on patient age, comorbidity burden, and tumor genetics.
Chemotherapy-induced bone marrow suppression:
Chemotherapeutic agents exert non-selective cytotoxic effects, eradicating both neoplastic cells and rapidly dividing healthy somatic cells.
Neutropenia is a major dose-limiting toxic effect, rendering patients profoundly susceptible to life-threatening opportunistic infections.
Hematologic malignancy conditioning: In leukemias and lymphomas, therapeutic protocols intentionally induce total bone marrow ablation to prepare the patient for bone marrow transplantation; a significant proportion of patients succumb to overwhelming infectious complications during this pre-engraftment aplastic window.
Nursing interventions for neutropenia: Strict adherence to protective personal protective equipment (PPE), rigorous aseptic technique, and mandatory nurse self-advocacy (e.g., requesting reassignment if exhibiting minor viral symptoms such as a common sniffle to prevent fatal patient cross-contamination).
Diagnostic Cascade and Cancer Staging
Clinical Manifestations:
Early presentation: Frequently insidiously masked by chronic smoker symptoms (e.g., morning cough). Patients seek evaluation when manifestations diverge from baseline, including acute dyspnea, acute respiratory distress, hemoptysis, or unresolving localized chest pain.
Late manifestations: Progressive systemic deterioration involving multi-organ dysfunction and profound constitutional decline.
Diagnostic Sequence:
1. Chest X-ray: Initial imaging to identify parenchymal lesions .
2. Computed Tomography (CT / CAT Scan): Provides high-resolution cross-sectional visualization when plain radiography is non-diagnostic or to characterize suspicious parenchymal abnormalities.
3. Diagnostic Biopsy: Retrieval of suspicious cellular tissue sent directly to pathology for histological verification and tumor typing.
4. Positron Emission Tomography (PET Scan): Functional metabolic imaging conducted post-biopsy to determine distant metastatic spread.
TNM Staging System (Democri reference):
T: Primary tumor size and local anatomical extent.
N: Involvement of regional lymphatic nodes.
M: Presence or absence of distant metastatic disease.
Clinical Stages of Lung Cancer:
Stage I: Neoplasm is small and completely localized to the pulmonary tissue without regional lymph node involvement (subdivided into Stage IA and Stage IB). Represents the highest survival probability.
Stage II: Increased primary tumor dimensions with localized spread to adjacent intrapulmonary or hilar lymph nodes.
Stage III: Locally advanced malignancy extending into regional anatomical structures, including the mediastinum or the chest wall.
Stage IV: Advanced distant metastasis to extrathoracic organs or the contralateral hemithorax.
Thoracic Surgical Procedures and Anatomical Considerations
Normal Pulmonary Anatomy:
The human body contains two lungs comprising a total of five lobes.
Right lung: Three lobes (right upper, right middle, right lower).
Left lung: Two lobes (left upper, left lower).
Surgical Resection Classifications:
Pneumonectomy: Total surgical excision of an entire lung.
Lobectomy: Total excision of an individual anatomical lobe.
Segmental Resection / Partial Resection: Excision of a localized sub-lobar anatomical bronchopulmonary segment.
Postoperative Auscultation and Physical Assessment:
Stethoscope placement must bypass bony structures: auscultate superiorly above and inferiorly below the clavicles, as well as posteriorly around the borders of the scapulae.
Following partial/segmental resection: Diminished breath sounds are expected over the remaining operative lung segment.
Following complete lobectomy or pneumonectomy: Breath sounds over the vacated thoracic cavity are completely absent.
Thoracic Fluid Dynamics and Remaining Lung Protection:
Surgical tissue disruption causes localized trauma and immediate transudative/exudative fluid accumulation within the vacated thoracic cavity.
The remaining ipsilateral or contralateral lung tissue experiences acute workload hyper-expansion and compensatory vascular pressure, increasing the risk for pneumothorax or acute alveolar overload.
Postoperative air hunger may induce compensatory hyperventilation, exacerbating pulmonary strain.
Prioritize the unaffected ("good") lung through rigorous infection control (meticulous hand hygiene) to prevent Hospital-Acquired Infections (HAI) and Hospital-Acquired Pneumonia (HAP).
Mechanically ventilated patients require adherence to ventilator-associated pneumonia (VAP) prevention bundles, continuous verification of ventilator settings, and frequent pulmonary auscultation for adventitious sounds (crackles, wheezes, rhonchi).
Thoracic Drainage Systems:
Traditional underwater seal chest tubes serve specifically to evacuate trapped air or blood, thereby re-establishing negative intrapleural pressure to re-inflate an atelectatic or collapsed lung.
Following a partial or segmental resection, a traditional chest tube is routinely placed to facilitate the re-expansion of the remaining lobar tissue and preserve pleural integrity.
Following complete pneumonectomy, traditional chest tubes to continuous suction are contraindicated (as the hemithorax is permitted to fill with serosanguinous fluid to stabilize the mediastinum); closed suction bulb drains (such as Jackson-Pratt [JP] drains) may be utilized strictly for surgical tissue drainage.
Tracheal deviation represents a critical clinical emergency reflecting severe intrathoracic pressure shifts toward the path of least resistance or traction toward the healthy lung, requiring immediate provider notification.
Patient Positioning and Clinical Management
Positioning in Non-Surgical Pulmonary Disease (Aspiration Pneumonia Clinical Vignette):
A 90-year-old female admitted to a Medical-Surgical unit with right-sided aspiration pneumonia preferred positioning exclusively on her affected right side for personal comfort.
Static positioning on the dependent, diseased lung led to dense pulmonary consolidation and rapid, shallow tachypnea throughout the day.
General physiological positioning rule:
If arterial oxygen saturation () declines, turn the patient with the good lung dependent (good lung down) to optimize perfusion to well-ventilated alveoli via gravity.
If oxygen saturation remains stable, elevate the diseased lung upward to facilitate gravitational drainage and mobilization of pooled bronchial secretions.
Frequent rotational repositioning, early physical mobilization, and aggressive incentive spirometry are vital in geriatric populations to achieve active alveolar recruitment.
Post-Thoracotomy Positioning Protocols:
Elevate the head of the bed to a semi-Fowler's or high-Fowler's position to optimize diaphragmatic excursion.
A slight tilt toward the operative side is acceptable to permit fluid accumulation in the operative hemithorax, but never position the patient completely onto their lateral decubitus side directly over the surgical incision.
Patients with indwelling chest tubes must never be positioned directly onto the drainage insertion site to avoid tube occlusion, mechanical tissue damage, and pressure injury development.
Preoperative and Postoperative Nursing Care
Preoperative Nursing Interventions:
Perform pre-procedure baseline incentive spirometry while both lungs are intact; this established numeric volume serves as the postoperative target for alveolar re-expansion.
Educate the patient on controlled diaphragmatic breathing techniques.
Provide anticipatory guidance regarding postoperative sensations of air hunger, reassuring the patient that dyspneic sensations may occur despite adequate arterial oxygenation.
Educate the patient regarding the anticipated presence, function, and securement of thoracic drains and chest tube collection systems.
Postoperative Nursing Interventions:
Follow the post-thoracotomy plan of care outlined in textbook Chart 19-23 (Care of the Patient After Thoracotomy / Lung Resection, alternately referenced as Chart 20-3).
Routinely inspect the surgical incision site for hematoma, serosanguinous discharge, erythema, and subcutaneous emphysema.
Actively manage chemotherapy- and radiation-induced side effects, nausea, fatigue, and pain to ensure compliance with deep breathing and coughing exercises.
Scope of Examination Preparation (NCLEX Focus):
Review oncologic principles encompassing lung carcinomas, intracranial neoplasms (addressed under neurological modules), reproductive tract malignancies, and differences between pediatric and adult acute and chronic leukemias.
Questions & Discussion
Question: Which specific histological classification of lung cancer is managed primarily with chemotherapy as its therapeutic mainstay?
Response: Small cell lung cancer (SCLC).
Question: In a patient presenting with the most common general distribution of lung cancer, where would a surgical resection anatomically be anticipated?
Response: In the upper pulmonary lobes, because these zones experience the highest concentration of direct particulate inhalation, cellular inflammation, and environmental exposure.
Question: What is the total anatomical lobe and lung count in the human body?
Response: There are two lungs containing a total of five lobes (three lobes within the right lung and two lobes within the left lung).
Question: What auscultatory breath sounds are expected postoperatively directly over the surgical area following a partial lobar resection?
Response: Diminished breath sounds are expected over the remaining, traumatized tissue of that operative lobe.
Question: What auscultatory breath sounds are expected over the left lower lung field if the entire left lower lobe has been surgically excised?
Response: Absent breath sounds; no lung sounds will be heard because the alveolar and bronchial tissue has been completely removed.
Question: Is a chest tube expected postoperatively following an intrathoracic resection?
Response: Yes, particularly for partial or segmental resections where remaining lung tissue within the pleural space must be re-inflated and maintained under negative pressure; specialized closed-suction bulb drains (such as JP drains) may be utilized for tissue fluid removal in other variations.
Question: What is the specific chart reference within the course textbook detailing the post-surgical nursing plan of care for lung resections?
Response: Chart 19-23 (titled "Care of the Patient After Thoracotomy"), also cross-referenced as Chart 20-3.